美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eisai Co., Ltd.

7.32

+0.11001.53%

成交量：21.11萬

成交額：153.01萬

市值：83.26億

市盈率：41.36

高：7.33

開：7.30

低：7.27

收：7.21

52周最高：9.22

52周最低：5.69

股本：11.37億

流通股本：10.77億

量比：2.51

換手率：0.02%

股息：0.24

股息率：3.34%

每股收益(TTM):0.1770

每股收益(LYR):0.2444

淨資產收益率：4.52%

總資產收益率：1.95%

市淨率：1.52

市盈率(LYR):29.95

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

財報前瞻｜Eisai Co., Ltd.本季度營收預計增10.45%，機構觀點偏謹慎

FDA批准勃健(BIIB)阿爾茨海默病新藥皮下劑型拓展居家治療應用場景

默沙東與衞材公布Litespark-012三期試驗進展評估晚期腎細胞癌一線聯合療法

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ESAIY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESAIY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","market":"US","secType":"STK","nameCN":"Eisai Co., Ltd.","latestPrice":7.32,"timestamp":1785268800000,"preClose":7.21,"halted":0,"volume":211060,"delay":15,"changeRate":0.015256588072122098,"floatShares":1076747898,"shares":1137465824,"eps":0.176978,"marketStatus":"盤前交易","change":0.11,"latestTime":"07-28 16:00:00 EDT 延時","open":7.295,"high":7.33,"low":7.2679,"amount":1530075.3388999996,"amplitude":0.008613,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.176978,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1785331800000},"marketStatusCode":1,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":7.32,"volumeRatio":2.5139119184013055},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","floatShares":1076747898,"roa":"1.95%","roe":"4.52%","lyrEps":0.244385,"volumeRatio":2.5139119184013055,"shares":1137465824,"dividePrice":0.24444,"high":7.33,"amplitude":0.008613,"preClose":7.21,"low":7.2679,"week52Low":5.6871,"pbRate":"1.52","psRate":"1.65","week52High":9.22,"institutionHeld":0,"latestPrice":7.32,"eps":0.176978,"divideRate":0.033393,"volume":211060,"delay":15,"ttmEps":0.176978,"open":7.295,"prevYearClose":7.38,"prevWeekClose":7.1,"prevMonthClose":6.27,"prevQuarterClose":6.27,"fiveDayClose":6.88,"twentyDayClose":6.37,"sixtyDayClose":7.49,"earningDate":1785686400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESAIY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-02-06","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":null},{"date":"2024-08-01","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722542400000,"name":null,"time":"盤後","dateTimestamp":1722484800000,"actualEps":null},{"date":"2024-05-14","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715716800000,"name":null,"time":"盤後","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESAIY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESAIY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.125,"hold":0.6875,"sell":0.0625,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6875,"analysts":16,"updateTime":1783569600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESAIY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193548551","title":"財報前瞻｜Eisai Co., Ltd.本季度營收預計增10.45%，機構觀點偏謹慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1193548551","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1193548551?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 09:13","pubTimestamp":1785114814,"startTime":"0","endTime":"0","summary":"Eisai Co., Ltd.将于2026年08月03日发布财报，市场关注新药放量与费用投入权衡对利润的影响。市场一致预期本季度营收为2,166.11亿日元，同比增长10.45%，预计调整后每股收益为50.73日元，同比增长8.71%；若公司在上季度电话会上发布了本季度的毛利率、净利率或净利润预测，但目前未检索到可信数据，则不做展示。公司上季度的业绩呈现“收入增长而利润承压”，净利率受研发、商业化及一次性因素影响走低。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Eisai Co., Ltd.本季度营收预计增10.45%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESAIY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651754101","title":"FDA批准勃健(BIIB)阿爾茨海默病新藥皮下劑型 拓展居家治療應用場景","url":"https://stock-news.laohu8.com/highlight/detail?id=2651754101","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651754101?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 16:31","pubTimestamp":1784017876,"startTime":"0","endTime":"0","summary":"本次剂型获批基于严谨的临床对比数据，临床试验证实，Leqembi皮下注射剂型的治疗效果、药效稳定性与原有静脉注射剂型高度一致，疗效水平无显著差异。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/NDk1MmZiNjQzNDA1OTQ5NDMzMQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDk1MmZiNjQzNDA1OTQ5NDMzMQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302523","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","BK4588","LABU","BMED","BIIB","IBRN","BK4007","LU0320765992.SGD","LU0109394709.USD","BK4533","IE00B19Z9Z06.USD","LU0234570918.USD","BK4532","ESALF","MNTL","IE00B894F039.SGD","BK4139","ESAIY","BK4585","LU0889565916.HKD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188634616","title":"默沙東與衞材公布Litespark-012三期試驗進展 評估晚期腎細胞癌一線聯合療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1188634616","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188634616?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 18:53","pubTimestamp":1776768798,"startTime":"0","endTime":"0","summary":"默沙东（Merck）与合作伙伴卫材（Eisai）近日联合公布了Litespark-012三期临床试验的最新进展。该项研究旨在评估针对特定晚期肾细胞癌患者的一线联合治疗方案疗效。\n这项关键性试验聚焦于创新疗法的临床验证，为晚期肾细胞癌患者提供新的治疗可能性。两家公司通过深度合作，持续推进肿瘤治疗领域的研发突破。\n随着临床试验数据的逐步完善，研究人员将进一步分析联合疗法的安全性与有效性指标。该研究结果有望为晚期肾细胞癌的一线治疗制定新标准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044949.HKD","LU1989772840.SGD","BK4550","IE0002141913.USD","MRK","LU0432979614.USD","LU0266013472.USD","LU0265550946.USD","LU1023059063.AUD","LU0942090050.USD","LU1037948897.HKD","LU1291159041.SGD","IE00BLSP4239.USD","LU0965509101.SGD","LU0265550359.USD","LU0106261372.USD","LU2125154778.USD","SG9999013999.USD","LU1066051225.USD","IE00B4R5TH58.HKD","LU2125154935.USD","LU2361045086.USD","LU2023250504.SGD","LU1037948541.HKD","LU2468319806.SGD","LU1069347547.HKD","LU0965508806.USD","LU0098860793.USD","BK4585","SG9999002232.USD","LU1093756325.SGD","SG9999014559.SGD","LU1093756168.USD","LU0648001328.SGD","LU0122379950.USD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU2361044865.SGD","LU1066051498.USD","LU0859254822.USD","BK4534","ESAIY","BK4533","LU1934455277.USD","LU0203345920.USD","LU1116320737.USD","IE00BLSP4452.SGD","IE00BJT1NW94.SGD","LU1066051811.HKD","SG9999001176.USD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU1974910355.USD","LU1983299246.USD","LU0289739699.SGD","LU2106854487.HKD","LU2357627491.SGD","LU1699723380.USD","LU0477156953.USD","SG9999002224.SGD","LU0320765489.SGD","LU1941712264.USD","LU0868494617.USD","LU0861579265.USD","LU1116320901.HKD","LU0238689110.USD","SG9999014575.USD","BK4516","LU0868494708.USD","SG9999014542.SGD","LU0208291251.USD","LU0985320562.USD","SG9999015341.SGD","LU1162221912.USD","LU0203347892.USD","LU2089984988.USD","SGXZ57979304.SGD","LU2023250843.SGD","IE000M9KFDE8.USD","LU0980610538.SGD","LU1989771016.USD","LU0058720904.USD","LU2461242641.AUD","LU1941712348.USD","LU1585245621.USD","LU2324357040.USD","LU1934455863.HKD","LU0234572021.USD","LU0006306889.USD","LU2360032135.SGD","LU1201861249.SGD","LU1057294990.SGD","LU1430594728.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","SG9999015358.SGD","LU1035773651.USD","BK4007","LU1929549753.HKD","BK4559","BK4588","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","SG9999001440.SGD","SG9999014567.USD","LU1571399168.USD","LU1989772923.USD","LU0130102774.USD","LU0211331839.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0070302665.USD","LU1934455194.USD","LU1917777945.USD","LU0130517989.USD","LU0320765646.SGD","IE00B1BXHZ80.USD","LU2112291526.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ESAIY\",params:#limit:6,delay:false,,,undefined,":[]}}